Gilead to Boost Stake in Belgian Biotech Galapagos as Part of $5.1 Billion Deal - The Wall Street Journal

Gilead to Boost Stake in Belgian Biotech Galapagos as Part of $5.1 Billion Deal  The Wall Street Journal

Gilead Sciences will pay $5.1 billion to lift its stake in Galapagos NV and gain rights outside Europe to the Belgian biotechnology company's treatments in ...

View full coverage on Google News

from Top stories - Google News https://ift.tt/2NUNtjO

Comments

Popular posts from this blog

U.S.-Canada 4 Nations Face-Off final draws 9.3 million viewers, most-watched NHL-sanctioned game in decades - The New York Times

Georgia hospitals test ‘game-changer’ pancreatic cancer drugs - Atlanta Journal-Constitution

Before Carlos Alcaraz Was Great, He Was Good Enough to Be Lucky - The New York Times